EOLS – Evolent Health Inc.
EOLS — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
15.29
Margin Of Safety %
Put/Call OI Ratio
0.39
EPS Next Q Diff
EPS Last/This Y
0.68
EPS This/Next Y
0.36
Price
4.08
Target Price
14.67
Analyst Recom
1.29
Performance Q
-32.56
Upside
-786.3%
Beta
1.13
Ticker: EOLS
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | EOLS | 5.36 | 0.42 | 2.09 | 14788 |
| 2026-03-10 | EOLS | 5.29 | 0.42 | 8.33 | 14763 |
| 2026-03-11 | EOLS | 5.39 | 0.42 | 999.99 | 14814 |
| 2026-03-12 | EOLS | 4.91 | 0.42 | 2.12 | 14811 |
| 2026-03-13 | EOLS | 4.91 | 0.42 | 1.96 | 14811 |
| 2026-03-17 | EOLS | 4.92 | 0.45 | 47.00 | 14964 |
| 2026-03-18 | EOLS | 4.84 | 0.46 | 0.43 | 15025 |
| 2026-03-19 | EOLS | 4.86 | 0.46 | 1.67 | 15040 |
| 2026-03-20 | EOLS | 4.64 | 0.46 | 0.02 | 15056 |
| 2026-03-23 | EOLS | 4.68 | 0.39 | 0.32 | 13618 |
| 2026-03-24 | EOLS | 4.44 | 0.39 | 0.95 | 13628 |
| 2026-03-25 | EOLS | 4.36 | 0.39 | 0.33 | 13634 |
| 2026-03-26 | EOLS | 4.18 | 0.39 | 1.36 | 13772 |
| 2026-03-27 | EOLS | 4.01 | 0.39 | 2.43 | 13798 |
| 2026-03-30 | EOLS | 3.94 | 0.40 | 0.75 | 13816 |
| 2026-03-31 | EOLS | 4.11 | 0.39 | 0.00 | 13754 |
| 2026-04-01 | EOLS | 4.3 | 0.39 | 0.02 | 13761 |
| 2026-04-02 | EOLS | 4.03 | 0.39 | 2.94 | 13813 |
| 2026-04-06 | EOLS | 4.17 | 0.39 | 0.00 | 13847 |
| 2026-04-07 | EOLS | 4.09 | 0.39 | 0.71 | 13857 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | EOLS | 5.37 | 30.9 | 21.7 | -0.12 |
| 2026-03-10 | EOLS | 5.29 | 30.9 | 15.2 | -0.12 |
| 2026-03-11 | EOLS | 5.39 | 30.9 | 14.8 | -0.12 |
| 2026-03-12 | EOLS | 4.92 | 30.9 | 16.1 | -0.12 |
| 2026-03-13 | EOLS | 5.02 | 30.9 | 14.7 | -0.12 |
| 2026-03-17 | EOLS | 4.91 | 30.9 | 15.4 | -0.12 |
| 2026-03-18 | EOLS | 4.84 | 30.9 | 15.2 | -0.12 |
| 2026-03-19 | EOLS | 4.87 | 30.9 | 14.9 | -0.12 |
| 2026-03-20 | EOLS | 4.64 | 30.9 | 15.6 | -0.12 |
| 2026-03-23 | EOLS | 4.69 | 30.9 | 14.9 | -0.12 |
| 2026-03-24 | EOLS | 4.43 | 30.9 | 15.7 | -0.12 |
| 2026-03-25 | EOLS | 4.36 | 30.9 | 15.2 | -0.12 |
| 2026-03-26 | EOLS | 4.18 | 30.9 | 15.5 | -0.12 |
| 2026-03-27 | EOLS | 4.01 | 30.9 | 15.5 | -0.12 |
| 2026-03-30 | EOLS | 3.95 | 30.9 | 15.2 | -0.12 |
| 2026-03-31 | EOLS | 4.11 | 30.9 | 14.6 | -0.12 |
| 2026-04-01 | EOLS | 4.30 | 30.9 | 11.4 | -0.12 |
| 2026-04-02 | EOLS | 4.02 | 30.9 | 12.9 | -0.12 |
| 2026-04-06 | EOLS | 4.16 | 30.9 | 11.5 | -0.12 |
| 2026-04-07 | EOLS | 4.08 | 30.9 | 12.2 | -0.12 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | EOLS | -0.08 | -9.09 | 15.65 |
| 2026-03-10 | EOLS | -0.08 | -9.09 | 15.65 |
| 2026-03-11 | EOLS | -0.08 | -9.09 | 15.67 |
| 2026-03-12 | EOLS | -0.08 | -9.09 | 15.67 |
| 2026-03-13 | EOLS | -0.08 | -9.09 | 15.67 |
| 2026-03-17 | EOLS | -0.08 | -9.08 | 15.67 |
| 2026-03-18 | EOLS | -0.08 | -9.08 | 15.67 |
| 2026-03-19 | EOLS | -1.04 | -9.08 | 15.67 |
| 2026-03-20 | EOLS | -1.04 | -9.08 | 15.67 |
| 2026-03-23 | EOLS | -1.14 | -9.08 | 15.67 |
| 2026-03-24 | EOLS | -1.14 | -9.08 | 15.67 |
| 2026-03-25 | EOLS | -1.14 | -9.08 | 15.29 |
| 2026-03-26 | EOLS | -1.14 | -9.08 | 15.29 |
| 2026-03-27 | EOLS | -1.14 | -9.08 | 15.29 |
| 2026-03-30 | EOLS | -1.14 | -9.18 | 15.29 |
| 2026-03-31 | EOLS | -1.14 | -9.18 | 15.29 |
| 2026-04-01 | EOLS | -1.14 | -9.18 | 15.29 |
| 2026-04-02 | EOLS | -1.14 | -9.18 | 15.29 |
| 2026-04-06 | EOLS | -1.14 | -9.17 | 15.29 |
| 2026-04-07 | EOLS | -1.14 | -9.17 | 15.29 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.12
Avg. EPS Est. Next Quarter
-0.05
Insider Transactions
-1.14
Institutional Transactions
-9.17
Beta
1.13
Average Sales Estimate Current Quarter
72
Average Sales Estimate Next Quarter
82
Fair Value
Quality Score
34
Growth Score
48
Sentiment Score
18
Actual DrawDown %
77.1
Max Drawdown 5-Year %
-77.4
Target Price
14.67
P/E
Forward P/E
20.07
PEG
P/S
0.89
P/B
P/Free Cash Flow
EPS
-0.8
Average EPS Est. Cur. Y
-0.12
EPS Next Y. (Est.)
0.24
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-17.38
Relative Volume
0.49
Return on Equity vs Sector %
196
Return on Equity vs Industry %
216.2
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.05
EBIT Estimation
12.2
◆
EOLS
Healthcare
$4.08
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
39.8
Range 1M
13.8%
Sup Dist
1.7%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
63.6%
EPS NY
227.1%
52W%
3%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+149.8% upside
Upside
+149.8%
Quality
34
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 334
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
EOLS
Latest News
—
Caricamento notizie per EOLS…
stock quote shares EOLS – Evolent Health Inc. Stock Price stock today
news today EOLS – Evolent Health Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolent Health Inc. yahoo finance google finance
stock history EOLS – Evolent Health Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading